NCT05269329View on ClinicalTrials.gov

Efficacy and Safety of XC8, Film-coated Tablets, 10 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection

PHASE2CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

April 26, 2021

Primary Completion Date

October 26, 2021

Study Completion Date

October 26, 2021

Conditions
Common ColdAcute Respiratory InfectionInfluenza, Human
Interventions
DRUG

XC8, film-coated tablets, 20 mg/day

20 mg/day (1 tablet twice a day)

DRUG

XC8, film-coated tablets, 40 mg/day

40 mg/day (2 tablets twice a day)

DRUG

XC8, film-coated tablets, 80 mg/day

80 mg/day (4 tablets twice a day)

DRUG

Placebo

1, 2, or 4 tablets twice a day

Trial Locations (9)

119571

Unimed-C Jsc, Moscow

150000

Medical Diagnostic Center LLC., Yaroslavl

153025

Ivanovo Kuvaev Clinical Hospital, Ivanovo

194000

EosMED JSC, Saint Petersburg

194156

Aurora MedFort LLC, Saint Petersburg

195271

"Private Healthcare Institution Clinical Hospital RZD-Medicine of St. Petersburg", Saint Petersburg

199178

OrKli Hospital LLC., Saint Petersburg

610027

Kirov State Medical University, Kirov

614070

Professors' Clinic LLC., Perm

All Listed Sponsors
lead

Valenta Pharm JSC

INDUSTRY